S. 3819 · 117th Congress
ARPA–H Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
MurraySponsor1 cosponsor · 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Advanced Research Project Authority for Health Act or the ARPA-H Act
What it does: CRS summary · Introduced in Senate · Mar 10, 2022
Advanced Research Project Authority for Health Act or the ARPA-H Act
This bill establishes within the National Institutes of Health (NIH) the Advanced Research Projects Authority for Health to accelerate innovation in health and medicine by investing in high-risk, high-reward research projects. The bill also establishes an interagency advisory committee to inform the authority's activities.
The authority director shall be appointed by the President and report to the NIH director. The authority director must, among other duties, designate personnel to serve as program managers who select projects to support, make recommendations about terminating or continuing projects, and otherwise administer authority programs.
The authority may use a variety of mechanisms to support the research projects, including grants, contracts, and prize competitions. To receive funding, an applicant must demonstrate sufficient, unsuccessful attempts to secure private funding for its project and other criteria. Furthermore, the authority's budget is separate from the NIH budget.
In addition, the authority must (1) develop and periodically update a strategic plan, (2) annually report on its activities, and (3) seek to contract with the National Academies of Sciences, Engineering, and Medicine to evaluate the authority's performance.
The Food and Drug Administration (FDA) may meet with the authority and other federal partners to discuss actions to facilitate the development of medical projects and products prioritized by the authority. The authority must reimburse the FDA for the costs associated with supporting authority activities.
The bill also requires the Government Accountability Office to report on issues related to the authority's hiring and staffing.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: ARPA–H Act
Also known as: Advanced Research Project Authority for Health Act
Latest action (Mar 10, 2022): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Mar 10, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.